The food, drug and medical device industries comprise some of the most closely regulated sectors in the United States. The US Food & Drug Administration (FDA) actively exercises authority by constantly changing legislation and policies to keep pace with transformative technologies and emerging public health concerns. Issues such as artificial intelligence (AI), compounding, cannabis and national security are at the forefront of broadcast media and trade press, but they represent only a subset of regulatory focus areas potentially impacted this year.
In this report we describe several actions, taking shape in 2024 by the federal government, that are expected to have broad impact within the food, drug and medical device industries. The summary is intended to focus on those actions that are most highly anticipated and is not meant to provide an exhaustive overview of all federal regulations or guidance affecting these industries. Readers should keep in mind that individual states also promulgate regulations and guidance that could impact the sectors.
